Glaxo Wellcome - EU prohibits drug-pricing policy

被引：0
|
作者：
不详
机构：
来源：
CHEMISTRY & INDUSTRY | 1999年 / 15期
关键词：
D O I：
暂无
中图分类号：
O69 [应用化学];
学科分类号：
081704 ;
摘要：
引用
收藏
页码：575 / 575
页数：1
相关论文
共 50 条
  • [1] The Future of Drug-Pricing Transparency
    Feldman, William B.
    Rome, Benjamin N.
    Avorn, Jerry
    Kesselheim, Aaron S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (06): : 489 - 491
  • [2] Glaxo Wellcome, SmithKline Beecham merger cleared by EU
    不详
    [J]. CHEMICAL & ENGINEERING NEWS, 2000, 78 (20) : 18 - 18
  • [3] GLAXO-WELLCOME BACKS DRUG CENTER
    不详
    [J]. CHEMICAL ENGINEER-LONDON, 1995, (598): : 8 - 8
  • [4] Madrid - Pharmaceutical companies sent reeling by drug-pricing policy in Spain
    Bosch, X
    [J]. LANCET, 2000, 355 (9209): : 1081 - 1081
  • [5] Applications of pharmacogenetics to drug development: The Glaxo Wellcome experience
    Arledge, T
    Freeman, A
    Arbuckle, J
    Mosteller, M
    Manasco, P
    [J]. DRUG METABOLISM REVIEWS, 2000, 32 (3-4) : 387 - 394
  • [6] London - Will UK drug-pricing regulation be abolished?
    Dean, M
    [J]. LANCET, 1998, 352 (9134): : 1127 - 1127
  • [7] Glaxo Wellcome to help develop drug discovered British Biotech
    不详
    [J]. BIOTECHNOLOGY LAW REPORT, 1995, 14 (06): : 993 - 994
  • [8] Analyzing Upward Deviation of Actual vs Predicted Drug Sales in Japan for a Reasonable Drug-Pricing Policy
    Shibata, Shoyo
    Fukumoto, Daigo
    Suzuki, Takeshi
    Ozaki, Koken
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019,
  • [9] Analyzing Upward Deviation of Actual vs Predicted Drug Sales in Japan for a Reasonable Drug-Pricing Policy
    Shoyo Shibata
    Daigo Fukumoto
    Takeshi Suzuki
    Koken Ozaki
    [J]. Therapeutic Innovation & Regulatory Science, 2020, 54 : 544 - 551
  • [10] Analyzing Upward Deviation of Actual vs Predicted Drug Sales in Japan for a Reasonable Drug-Pricing Policy
    Shibata, Shoyo
    Fukumoto, Daigo
    Suzuki, Takeshi
    Ozaki, Koken
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (03) : 544 - 551
12345